On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – September 20, 2023 – USA News Group  –  Earlier this year, the US White House requested over $2.8 billion in funding from Congress for their  “Cancer Moonshot” initiative, an ambitious plan to slash cancer rates in half within the next quarter-century. Already, […]

Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation

NetworkNewsWire Editorial Coverage   New York, NY – September 20, 2023 – More than 30 million people in the United States suffer with a rare disease; most of them are receiving no current treatment. Supporting the development and evaluation of new treatments, particularly for rare diseases, is a key priority for the U.S. Food & […]

Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise

Palm Beach, FL – September 20, 2023 – FinancialNewsMedia.com News Commentary – The demand for abuse deterrent formulation technology is projected to grow due to growing misuse of drugs among the people. Growing demand for abuse deterrent formulation technology from the pharmaceutical industry is driving the market growth. Abuse-deterrent formulations are used to decrease the […]

Nutriband Announces Issuance of U.S. Patent for Transdermal Abuse Deterrent Technology

Patent issuance expands U.S. patent portfolio for AVERSA™ transdermal abuse deterrent technology   Orlando, FL – September 20, 2023 – Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that the United States Patent and Trademark Office (USPTO) has granted US Patent No. 11,759,431 for Nutriband’s proprietary AVERSA™ abuse deterrent technology utilizing […]